Jpmorgan Chase & CO Evolent Health, Inc. Transaction History

Jpmorgan Chase & CO

$1.22 Trillion
Q3 2024

A detailed history of Jpmorgan Chase & CO transactions in Evolent Health, Inc. stock. As of the latest transaction made, Jpmorgan Chase & CO holds 4,116,045 shares of EVH stock, worth $45.7 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

4,116,045

Previous 4,354,740 5.48%

Holding current value

$45.7 Million

Previous $83.3 Million 39.8%

% of portfolio

0.01%

Previous 0.01%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 08, 2024	SELL	$18.41 - $32.97 $4.39 Million - $7.87 Million	-238,695 Reduced 5.48%	4,116,045 $116 Million
Q2 2024 Aug 12, 2024	SELL	$19.12 - $31.93 $7.5 Million - $12.5 Million	-392,367 Reduced 8.27%	4,354,740 $83.3 Million
Q1 2024 May 10, 2024	SELL	$29.41 - $34.72 $34.4 Million - $40.6 Million	-1,170,577 Reduced 19.78%	4,747,107 $156 Million
Q4 2023 Feb 12, 2024	SELL	$23.63 - $33.52 $3.09 Million - $4.38 Million	-130,802 Reduced 2.16%	5,917,684 $195 Million
Q3 2023 Nov 14, 2023	BUY	$25.0 - $31.4 $4.47 Million - $5.62 Million	178,993 Added 3.05%	6,048,486 $165 Million
Q2 2023 Aug 11, 2023	BUY	$28.05 - $36.44 $8.67 Million - $11.3 Million	308,943 Added 5.56%	5,869,493 $178 Million
Q1 2023 May 18, 2023	BUY	$26.35 - $35.8 $2.83 Million - $3.84 Million	107,216 Added 1.97%	5,560,550 $180 Million
Q1 2023 May 11, 2023	BUY	$26.35 - $35.8 $2.52 Million - $3.42 Million	95,458 Added 1.78%	5,453,334 $177 Million
Q4 2022 Feb 13, 2023	SELL	$22.21 - $37.41 $10.8 Million - $18.3 Million	-488,129 Reduced 8.35%	5,357,876 $150 Million
Q3 2022 Nov 14, 2022	SELL	$29.37 - $39.74 $7.44 Million - $10.1 Million	-253,244 Reduced 4.15%	5,846,005 $210 Million
Q2 2022 Aug 11, 2022	SELL	$25.9 - $32.26 $1.03 Million - $1.29 Million	-39,843 Reduced 0.65%	6,099,249 $187 Million
Q1 2022 May 11, 2022	BUY	$22.14 - $32.3 $849,378 - $1.24 Million	38,364 Added 0.63%	6,139,092 $198 Million
Q4 2021 Feb 10, 2022	SELL	$25.36 - $34.11 $2.76 Million - $3.71 Million	-108,769 Reduced 1.75%	6,100,728 $169 Million
Q3 2021 Nov 12, 2021	BUY	$20.93 - $31.0 $130 Million - $192 Million	6,209,497 New	6,209,497 $192 Million

Others Institutions Holding EVH

# of Institutions

307

Shares Held

124M

Call Options Held

2.13M

Put Options Held

2.64M

View Full List

About Evolent Health, Inc.

Ticker EVH
Exchange NYSE
Sector Healthcare
Industry Health Information Services
Shares Outstandng 97,063,696
Market Cap $1.08B
Description
Evolent Health, Inc., a healthcare company, through its subsidiary, Evolent Health LLC, provides clinical and administrative solutions to payers and providers in the United States. It operates in two segments, Evolent Health Services and Clinical Solutions. The Evolent Health Services segment provides an integrated administrative and clinical pl...

More about EVH

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Jpmorgan Chase & CO, based on Form 13F filings with the SEC.

News

Stay updated on Jpmorgan Chase & CO with notifications on news.

Account

Jpmorgan Chase & CO Evolent Health, Inc. Transaction History